NCT05604820

Brief Summary

Chemotherapy is applied as a standard method in the treatment of cancer, which is an important public health problem in terms of incidence and mortality. Sleep quality due to cancer and its treatments is adversely affected. Cognitive behavioral therapies, walking and relaxation exercises are known to be beneficial in increasing sleep quality. For this reason, this study will be conducted to evaluate the effect of progressive muscle relaxation exercises applied to individuals who are undergoing chemotherapy and whose sleep quality has deteriorated, on sleep quality. The research will be carried out between March and September 2022 in Konya City Hospital Chemotherapy Unit with patients undergoing chemotherapy. Patients who will receive chemotherapy will be informed about the study, and those who accept to participate in the study will be evaluated according to the inclusion and exclusion criteria of the sample selection. They will be asked to fill out the PUKI. It will then be assigned to the control or experimental group with the randomization program assignment. Training on progressive muscle relaxation exercises will be given to the experimental group in the chemotherapy unit. Before going to sleep in the evening and during the day, they will be asked to do progressive muscle relaxation exercises in line with the instruction of the video. They will be asked to do the application every day for 8 weeks. At the end of the 2nd week, 4th week, 6th week and 8th week, they will be asked to fill the PUKI again. Only routine care will be applied to the control group and no intervention will be made. At the end of the 2nd week, 4th week, 6th week and 8th week, they will be asked to fill the PUKI again. After the evaluations, information about progressive muscle relaxation exercises will be given.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

October 31, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 3, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2023

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

3 months

First QC Date

October 16, 2022

Last Update Submit

November 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • quality of sleep

    measuring the effect of progressive November relaxation exercise on sleep quality

    two months

Study Arms (2)

experimental

EXPERIMENTAL

Progressive Muscle Relaxation Exercise

Behavioral: Progressive Muscle Relaxation Exercise

no ıntervention

NO INTERVENTION

Interventions

Training on progressive muscle relaxation exercises will be given to the experimental group in the chemotherapy unit. Before going to sleep in the evening and during the day, they will be asked to do progressive muscle relaxation exercises in line with the instruction of the video. They will be asked to do the application every day for 8 weeks. At the end of the 2nd week, 4th week, 6th week and 8th week, they will be asked to fill the PUKI again. Only routine care will be applied to the control group and no intervention will be made. At the end of the 2nd week, 4th week, 6th week and 8th week, they will be asked to fill the PUKI again. After the evaluations, information about progressive muscle relaxation exercises will be given.

experimental

Eligibility Criteria

Age18 Years - 80 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pittsburgh Sleep Quality Index (PUKI) score, which is 5 points and above,
  • who are 18 years of age or older,
  • \* Who will receive outpatient chemotherapy in the chemotherapy unit,
  • Knows how to read and write,
  • Using mobile phone conveniently to upload progressive November relaxation exercise video, \* Who volunteered to participate in the research.

You may not qualify if:

  • \* Hearing impaired,
  • Receiving radiotherapy treatment,
  • Who has a physical disability to perform relaxation exercises,
  • Depression, schizophrenia, etc. with a diagnosis of psychiatric illness,
  • With neurological disorders,
  • With a metastatic condition,
  • Antidepressants or sleeping pills, etc. using medication,
  • Relaxation exercise (yoga, breathing and meditation, etc.) acting.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kto Karatay üniversitesi

Konya, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Due to the characteristics of the study, blinding cannot be applied to the participants. In order to eliminate the bias, the data of the study will be collected and recorded by an impartial researcher (assistant researcher) who does not know the groups trained by the researcher. The statistics of the research will be carried out by an independent statistician who does not know the groups. In this way, the prevention of bias will be ensured.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: A Randomized Controlled Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2022

First Posted

November 3, 2022

Study Start

October 31, 2022

Primary Completion

February 7, 2023

Study Completion

April 10, 2023

Last Updated

November 14, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations